文献速递肝病

全外显子组关联研究通过丙氨酸氨基转移酶识别GPAM和APOE序列变异与脂肪性肝病相关

Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
PubMed 文献 · Gastroenterology · 2021-02-06

该研究在英国生物银行425,671名参与者中全外显子组水平分析错义和无义变异与丙氨酸氨基转移酶的关联,并在8,930名有肝脏脂肪含量数据者中验证,在3个独立队列共2,621名有肝活检个体中重复2个遗传变异。鉴定出190个独立关联变异,其中GPAM/GPAT1的rs2792751和APOE的rs429358与肝脏脂肪含量及肝病稳健相关。

要点

  • GPAM的rs2792751和APOE的rs429358与肝脏脂肪含量及肝病稳健相关。
  • 全外显子组关联分析鉴定出190个与丙氨酸氨基转移酶独立相关的遗传变异。
  • 多数关联变异此前未与丙氨酸氨基转移酶关联,且富集于脂质代谢通路。

核心结论

  • 研究识别出GPAM和APOE两个新遗传变异与肝脏脂肪变性和肝损伤稳健相关,有助于阐明脂肪性肝病发病和进展的遗传易感性。

研究设计与样本

  • 研究首先在英国生物银行425,671名参与者中全外显子组水平检验错义和无义变异与丙氨酸氨基转移酶的关联。
  • 随后在8,930名有肝脏脂肪含量测量数据的参与者中验证遗传变异与肝脏脂肪含量的关联。
  • 最后在3个独立队列共2,621名有可用肝活检的个体中重复2个遗传变异。

主要发现

  • 经Bonferroni法多重检验校正后,鉴定出190个与丙氨酸氨基转移酶独立相关的遗传变异,其中大多数此前未与该性状关联。
  • 关联变异中影响脂质代谢的遗传变异显著富集。
  • GPAM/GPAT1的rs2792751和APOE的rs429358在多重检验校正后与肝脏脂肪含量及肝病稳健相关,两基因均影响肝脏脂质代谢。

临床怎么用

  • GPAM和APOE变异可作为脂肪性肝病遗传易感性评估的候选标记,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Fatty liver disease (FLD) is a growing epidemic that is expected to be the leading cause of end-stage liver disease within the next decade. Both environmental and genetic factors contribute to the susceptibility of FLD. Several genetic variants contributing to FLD have been identified in exome-wide association studies. However, there is still a missing hereditability indicating that other genetic variants are yet to be discovered. METHODS: To find genes involved in FLD, we first examined the association of missense and nonsense variants with alanine aminotransferase at an exome-wide level in 425,671 participants from the UK Biobank. We then validated genetic variants with liver fat content in 8930 participants in whom liver fat measurement was available, and replicated 2 genetic variants in 3 independent cohorts comprising 2621 individuals with available liver biopsy. RESULTS: We identified 190 genetic variants independently associated with alanine aminotransferase after correcting for multiple testing with Bonferroni method. The majority of these variants were not previously associated with this trait. Among those associated, there was a striking enrichment of genetic variants influencing lipid metabolism. We identified the variants rs2792751 in GPAM/GPAT1, the gene encoding glycerol-3-phosphate acyltransferase, mitochondrial, and rs429358 in APOE, the gene encoding apolipoprotein E, as robustly associated with liver fat content and liver disease after adjusting for multiple testing. Both genes affect lipid metabolism in the liver. CONCLUSIONS: We identified 2 novel genetic variants in GPAM and APOE that are robustly associated with steatosis and liver damage. These findings may help to better elucidate the genetic susceptibility to FLD onset and progression.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Jamialahmadi O, Mancina RM, Ciociola E, et al. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease. Gastroenterology. 2021. PMID: 33347879. doi:10.1053/j.gastro.2020.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。